Downregulation of Oct4 resulted in the reduction of glioma colony formation and cell proliferation in vitro and in vivo which indicates the vital role of Oct4 in tumorigenic activity in GBM self-renewal, aggressiveness, and pluripotency [17, 18]. This evidence concerns the gene POU5F1 and central nervous system cancer.